Document is current
Any future updates will be listed below
-
Authors
Vasiliev, Grigory
Kubo, Anna-Liisa
Vija, Heiki
Kahru, Anne
Bondar, Denys
Karpichev, Yevgen
Bondarenko, Olesja
-
Funding
Funding for this research was provided by:
EIC Accelerator grant (190199469)
Estonian Research Council grant (GOVSG16)
grant from Development Fund of National Institute of Chemical Physics and Biophysics (Arengufond_OB grant)
Grant from Estonian Research Council (PRG749)
European Regional Development Fund (TK134)
Grant from Estonian Research Agency (COVSG5)
- License Information
-
More Information
Article History
Received: 27 January 2023
Accepted: 4 June 2023
First Online: 6 June 2023
Competing interests
: A.-L.K., G.V., O.B. are co-founders of Nanordica Medical developing nanoparticle-based antibacterial products. A.K., D.B., H.V. and Y.K. declare no competing interests.
